News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Eli Lilly and Company Sues IMPAX Laboratories, Inc.
November 19, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Eli Lilly & Co. sued generic drug maker Impax Laboratories Inc. for patent infringement. The suit deals with an Impax copy of the Eli Lilly drug Cymbalta, an antidepressant.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Eli Lilly and Company
MORE ON THIS TOPIC
Vaccines
Former CDC, FDA Chiefs Decry Vaccine Policy Changes as ACIP Meeting Begins
December 4, 2025
·
2 min read
·
Dan Samorodnitsky
FDA
New Approach Methodologies: Redefining Animal Testing Alternatives
December 4, 2025
·
1 min read
·
BioSpace Insights
Policy
New UK/EU Rules and AI Adoption Define CRO Priorities for 2026
December 3, 2025
·
4 min read
·
Jennifer Smith-Parker
Vaccines
ACIP To Discuss Hep B, Childhood Vaccine Schedule Under New Chair Who Linked COVID Shots to Cancer
December 2, 2025
·
2 min read
·
Tristan Manalac